Trials / Completed
CompletedNCT00809471
Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D)
A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil (TA-1790) in the Treatment of Erectile Dysfunction in Diabetic Men
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 390 (actual)
- Sponsor
- VIVUS LLC · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to compare the safety and efficacy of 2 doses of avanafil to placebo in diabetic men with mild to severe erectile dysfunction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | 30 minutes orally prior to initiation of sexual activity |
| DRUG | avanafil | 30 minutes orally prior to initiation of sexual activity |
| DRUG | avanafil | 30 minutes orally prior to initiation of sexual activity |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2008-12-17
- Last updated
- 2012-08-17
- Results posted
- 2012-06-28
Locations
39 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00809471. Inclusion in this directory is not an endorsement.